BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 8886306)

  • 1. Cerebrospinal fluid transmitter metabolites and atmospheric pressure.
    Nordin C; Eklundh T
    Biol Psychiatry; 1996 Oct; 40(7):682-4. PubMed ID: 8886306
    [No Abstract]   [Full Text] [Related]  

  • 2. Cerebrospinal fluid monoamine metabolites and atmospheric pressure.
    Heilig M; Månsson JE; Blennow K
    Biol Psychiatry; 1996 Feb; 39(4):299-301. PubMed ID: 8645778
    [No Abstract]   [Full Text] [Related]  

  • 3. Monoamine precursors, transmitters and metabolites in cerebrospinal fluid: a prospective study in healthy male subjects.
    Eklundh T; Eriksson M; Sjöberg S; Nordin C
    J Psychiatr Res; 1996; 30(3):201-8. PubMed ID: 8884658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concentrations of cerebrospinal fluid monoamine metabolites in suicides.
    Lester D
    Psychol Rep; 1991 Feb; 68(1):146. PubMed ID: 1709746
    [No Abstract]   [Full Text] [Related]  

  • 5. Cerebrospinal fluid levels of monoamine compounds and cholecystokinin peptides after exposure to standardized barometric pressure.
    Eklundh T; Gunnarsson T; Ornhagen H; Nordin C
    Aviat Space Environ Med; 2000 Nov; 71(11):1131-6. PubMed ID: 11086668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cerebrospinal fluid monamine metabolites and cyclic nucleotides during alcoholic withdrawal syndrome].
    Fujimoto A
    Seishin Shinkeigaku Zasshi; 1980; 82(5):275-91. PubMed ID: 6157171
    [No Abstract]   [Full Text] [Related]  

  • 7. [CSF somatostatin and amine metabolites in spinocerebellar degenerations].
    Shimoda K; Hikasa C; Nishikawa S; Takahashi K
    Rinsho Shinkeigaku; 1987 Aug; 27(8):996-1001. PubMed ID: 2446812
    [No Abstract]   [Full Text] [Related]  

  • 8. Correlations between height of subject and concentrations of monoamine metabolites in cerebrospinal fluid from psychotic men and women.
    Wode-Helgodt B; Sedvall G
    Commun Psychopharmacol; 1978; 2(2):177-83. PubMed ID: 668302
    [No Abstract]   [Full Text] [Related]  

  • 9. The concentrations of amine metabolites in cerebrospinal fluid from normal and narcoleptic dogs [proceedings].
    Barchas JD; Dement WC; Faull K; Foutz AS; Holman RB
    J Physiol; 1979 Nov; 296():94P-95P. PubMed ID: 93641
    [No Abstract]   [Full Text] [Related]  

  • 10. Amine metabolites in the cerebrospinal fluid as a measure of central neurotransmitter function: methodological aspects.
    Bertilsson L; Asberg M
    Adv Biochem Psychopharmacol; 1984; 39():27-34. PubMed ID: 6205559
    [No Abstract]   [Full Text] [Related]  

  • 11. Amine metabolites in the ventricular cerebrospinal fluid of patients with ventricular dilatation. HPLC and clinical application (IV).
    Ikeda Y; Nakazawa S
    Nihon Ika Daigaku Zasshi; 1982; 49(6):848-50. PubMed ID: 6187766
    [No Abstract]   [Full Text] [Related]  

  • 12. [Amine metabolites in cerebrospinal fluids and thyrotropin releasing hormone in spinocerebellar degeneration].
    Arai M
    Rinsho Shinkeigaku; 1988 Jun; 28(6):595-604. PubMed ID: 2466598
    [No Abstract]   [Full Text] [Related]  

  • 13. Are monoamine metabolites in cerebrospinal fluid worth measuring?
    Potter WZ; Manji HK
    Arch Gen Psychiatry; 1993 Aug; 50(8):653-6. PubMed ID: 7688211
    [No Abstract]   [Full Text] [Related]  

  • 14. Genetics of monoamine metabolites in baboons: overlapping sets of genes influence levels of 5-hydroxyindolacetic acid, 3-hydroxy-4-methoxyphenylglycol, and homovanillic acid.
    Rogers J; Martin LJ; Comuzzie AG; Mann JJ; Manuck SB; Leland M; Kaplan JR
    Biol Psychiatry; 2004 Apr; 55(7):739-44. PubMed ID: 15039003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebrospinal fluid kynurenic acid in male and female controls - correlation with monoamine metabolites and influences of confounding factors.
    Nilsson LK; Nordin C; Jönsson EG; Engberg G; Linderholm KR; Erhardt S
    J Psychiatr Res; 2007; 41(1-2):144-51. PubMed ID: 16434056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of indeloxazine, (+)-2-[inden-7-yloxy)methyl]morpholine hydrochloride on cerebrospinal fluid monoamine metabolites.
    Mizuno Y; Shimabukuro T; Fukuzawa N
    Eur Neurol; 1988; 28(2):84-6. PubMed ID: 2453365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebrospinal fluid monoamine metabolites in narcolepsy and hypersomnia.
    Faull KF; Guilleminault C; Berger PA; Barchas JD
    Ann Neurol; 1983 Mar; 13(3):258-63. PubMed ID: 6189447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aminergic metabolites in cerebrospinal fluid of humans previously exposed to MDMA: preliminary observations.
    Ricaurte GA; Finnegan KT; Irwin I; Langston JW
    Ann N Y Acad Sci; 1990; 600():699-708; discussion 708-10. PubMed ID: 1701292
    [No Abstract]   [Full Text] [Related]  

  • 19. Blood glucose is correlated with cerebrospinal fluid neurotransmitter metabolites.
    Umhau JC; Petrulis SG; Diaz R; Rawlings R; George DT
    Neuroendocrinology; 2003 Dec; 78(6):339-43. PubMed ID: 14688447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biochemical correlates of suicidal behavior in arsonists.
    Lester D
    Psychol Rep; 1989 Feb; 64(1):258. PubMed ID: 2467320
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.